Cepheid (CPHD +4.8%) gets a boost from a Goldman upgrade to buy, noting the company's new...
Cepheid (CPHD +4.8%) gets a boost from a Goldman upgrade to buy, noting the company's new product opportunities, increased global TB testing, and improved top-line growth.
From other sites
at Zacks.com (Mar 27, 2015)
at 4-traders.com (Mar 24, 2015)
at Investor's Business Daily (Jan 14, 2015)
at Nasdaq.com (Jan 6, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs